Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT07486336
Starting soon Not applicable

Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.

NCT07486336 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2026-09-01
Last updated
2026-03-20

Condition(s) studied

FrailyAbdominal SurgeryPostoperative Cognitive Dysfunction (POCD)

Investigational drug(s) / intervention(s)

Neuraxial anesthesiaGeneral Anesthesiaavoidance of GABAergic-drugs strategyuse of GABAergic-drugsmechanical ventilation (MV)

Neuraxial anesthesia: patients undergo surgery with a neuraxial anesthesia based on spinal or epidural anesthesia using local anesthetics combined with sedation.

General Anesthesia: patients undergo surgery with a general anesthesia using classical GABAergic-drugs.

avoidance of GABAergic-drugs strategy: Sedation based on dexmedetomidine and low dosage of ketamine, avoiding GABAergic-drugs

use of GABAergic-drugs: General anesthesia using classical GABAergic-drugs such as propofol, remifentanil and rocuronium.

mechanical ventilation (MV): Abdomino-pelvic Surgery managed in general anesthesia needs orotracheal intubation and mechanical ventilation

Study summary

This is a bicentric, prospective, non-pharmacological, randomized study designed to compare the efficacy and safety of awake neuraxial anesthesia with sedation versus general anesthesia in frail patients undergoing elective major laparoscopic or robotic abdominopelvic surgery.

A total of 100 frail patients aged over 60 years, with ASA physical status \>2 and evidence of frailty and/or cognitive vulnerability, will be randomized to receive either standard general anesthesia with mechanical ventilation or thoracic neuraxial anesthesia combined with non-GABAergic sedation while maintaining spontaneous breathing.

The primary objective is to evaluate the feasibility in terms of recruitment of a RCT conducted in a population of frail or cognitively impaired patients undergoing major laparoscopic abdominal surgery, randomized to a neuraxial or general anesthetic approach in which the effects on the onset of postoperative delirium and postoperative cognitive dysfunction (POCD) will be determined. Secondary outcomes include the occurrence of postoperative organ dysfunction (respiratory, cardiovascular, renal, and metabolic), length of hospital stay, time to recovery after surgery, and postoperative mortality.

Patients will undergo comprehensive perioperative clinical, laboratory, and ultrasound assessments, including lung and renal ultrasound evaluations. Neurological and functional status will be assessed during hospitalization, at 1 month, and via telephone follow-up at 1 year after surgery.

The aim of the study is to evaluate the feasibility and safety of performing two different anesthetic techniques on fragile patients.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age \> 60 years * Willingness to participate in the study and written informed consent * ASA physical status \> 2 * Frailty score \> 5 and/or AMT-10 \< 6 * Laparoscopic or robotic major elective abdominopelvic surgery Exclusion Criteria: * Patients undergoing open (laparotomic) or emergency surgery, or presenting contraindications to central locoregional (neuraxial) anesthesia, specifically: * coagulation disorders * severe spinal deformities * known allergy to local anesthetics * severe aortic stenosis * systemic sepsis * infection at the puncture site * Any systemic disease that, in the investigator's judgment, is not compatible with participation in the study

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
E.O. Ospedali Galliera Genova Italy
AO di Circolo di Melegnano Vizzolo Predabissi Italy

More Ente Ospedaliero Ospedali Galliera trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07486336 on ClinicalTrials.gov ↗ ← All trials in Italy